These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 27033513)

  • 1. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
    Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
    Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
    Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
    Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.
    Liu Y; Ran R; Chen J; Kuang Q; Tang J; Mei L; Zhang Q; Gao H; Zhang Z; He Q
    Biomaterials; 2014 Jun; 35(17):4835-47. PubMed ID: 24651033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transferrin-conjugated magnetic silica PLGA nanoparticles loaded with doxorubicin and paclitaxel for brain glioma treatment.
    Cui Y; Xu Q; Chow PK; Wang D; Wang CH
    Biomaterials; 2013 Nov; 34(33):8511-20. PubMed ID: 23932498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood-brain barrier, and the transporting mechanism to glioma cells.
    Liu C; Liu XN; Wang GL; Hei Y; Meng S; Yang LF; Yuan L; Xie Y
    Int J Nanomedicine; 2017; 12():2407-2425. PubMed ID: 28405164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
    Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
    J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-sensitive folic acid and dNP2 peptide dual-modified liposome for enhanced targeted chemotherapy of glioma.
    Li M; Shi K; Tang X; Wei J; Cun X; Chen X; Yu Q; Zhang Z; He Q
    Eur J Pharm Sci; 2018 Nov; 124():240-248. PubMed ID: 30071282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
    Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
    J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.
    Gao JQ; Lv Q; Li LM; Tang XJ; Li FZ; Hu YL; Han M
    Biomaterials; 2013 Jul; 34(22):5628-39. PubMed ID: 23628475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of dual-functional liposomes containing paclitaxel for treatment of lung cancer.
    Wang RH; Cao HM; Tian ZJ; Jin B; Wang Q; Ma H; Wu J
    Oncol Rep; 2015 Feb; 33(2):783-91. PubMed ID: 25482610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT.
    Zong T; Mei L; Gao H; Shi K; Chen J; Wang Y; Zhang Q; Yang Y; He Q
    J Pharm Sci; 2014 Dec; 103(12):3891-3901. PubMed ID: 25339554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glioma targeted delivery strategy of doxorubicin-loaded liposomes by dual-ligand modification.
    Han W; Yin G; Pu X; Chen X; Liao X; Huang Z
    J Biomater Sci Polym Ed; 2017 Oct; 28(15):1695-1712. PubMed ID: 28699828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
    Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
    J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
    Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
    Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of nano-PTX to the brain tumor-associated macrophages.
    Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H
    Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.
    Wang X; Zhao Y; Dong S; Lee RJ; Yang D; Zhang H; Teng L
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31574945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomes actively recognizing the glucose transporter GLUT
    Fu Q; Zhao Y; Yang Z; Yue Q; Xiao W; Chen Y; Yang Y; Guo L; Wu Y
    Arch Pharm (Weinheim); 2019 Feb; 352(2):e1800219. PubMed ID: 30609116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-permeable NF-κB inhibitor-conjugated liposomes for treatment of glioma.
    Zhang Y; Zhang L; Hu Y; Jiang K; Li Z; Lin YZ; Wei G; Lu W
    J Control Release; 2018 Nov; 289():102-113. PubMed ID: 30243823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.